Close
Help
Need Help?
Search



Most Highly Accessed Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine Articles in July 2012

Posted Tue, Jul, 31,2012

These articles were the most highly accessed articles in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine in July 2012:

Omalizumab: Clinical Use for the Management of Asthma (accessed 395 times)

Neil C. Thomson and Rekha Chaudhuri

The DNR Order: What Does it Mean? (accessed 220 times)

John Y.C. Tsang

Use of the All Patient Refined-Diagnosis Related Group (APR-DRG) Risk of Mortality Score as a Severity Adjustor in the Medical ICU (accessed 180 times)

Daniel Baram, Feroza Daroowalla, Ruel Garcia, Guangxiang Zhang, John J. Chen, Erin Healy, Syed Ali Riaz and Paul Richman

Click on any article title to read the abstract and download the full text article PDF.

share on

Posted in: PubmedVisibility and Discoverability

News Categories

RECENT ENTRIES

Wed 22 May, 2013

Mycobacterium Update

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
testimonial_image
Working with the editorial staff and reviewers for Clinical Medicine Insights: Therapeutics was a positive experience.  The online submission/revision process was easy and staff were readily available to answer any questions.  Reviewers were knowledgeable, lending expert comments that allowed for improvement in content information.  I highly recommend others practitioners and researchers to consider Libertas Academica journals for their next publication.
LaNeigh Harkness (Texas Tech University Health Sciences Center, Lubbock, Texas, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results